RECRUITING
I'm interested ...!!
Aging and Frailty Study
The purpose of this research study is to compare methods to help personalize the prediction of chemotherapy side effects for older adults and to evaluate whether chemotherapy causes changes in the body that are associated with aging.
Conditions:
🦠 Effects of Chemotherapy 🦠 Aging 🦠 Frailty
🗓️ Study Start (Actual) 2 May 2022
🗓️ Primary Completion (Estimated) April 2025
✅ Study Completion (Estimated) April 2025
👥 Enrollment (Estimated) 25
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Winston-Salem, North Carolina, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Age 65 years and older
    • * Planned to initiate a new chemotherapy regimen
    • * Solid tumor malignancy of any stage or lymphoma
    • * Any performance status
    • * Ability to understand and the willingness to sign an IRB-approved informed consent document (either directly or via a legally authorized representative).
    • * Life expectancy of ≥3 months

    Exclusion Criteria:

    • * Initiating biologic, endocrine or immunotherapy only.
    • * Hematologic malignancy other than lymphoma.
    • * Concurrent radiation therapy.
    • * Planned inpatient chemotherapy.
Ages Eligible for Study: 65 Years to N/A (OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 15 February 2022
  • First Submitted that Met QC Criteria 24 February 2022
  • First Posted 7 March 2022

Study Record Updates

  • Last Update Submitted that Met QC Criteria 29 July 2024
  • Last Update Posted 30 July 2024
  • Last Verified July 2024
I'm interested ...!!